📧 Communication

email

Communication Details

From
To
Jeffrey Epstein Jeffrey Epstein
Date
July 24, 2015
Subject
Fwd: FDA Approved a Potent and Pricey Cholesterol lowering drug today
Message Content

Sender asks 'Have you heard of this colestrol' and forwards a Forbes article about a new drug called Praluent.

📄 Source Document

HOUSE_OVERSIGHT_025888.jpg
ESTATE Collection
View Document
Document Summary

This document is an email from Sultan Bin Sulayem to Jeffrey Epstein dated July 24, 2015. Sulayem forwards a Forbes article regarding the FDA approval of a new cholesterol-lowering drug called Praluent (by Regeneron Pharmaceuticals) and asks Epstein if he has heard of it. The document bears a House Oversight Bates stamp.

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein communication